The entry of human immunodeficiency virus (HIV-1) into host cells is mediated by the viral envelope glycoproteins (Envs), which are derived by the proteolytic cleavage of a trimeric gp160 Env precursor. The mature Env trimer is a major target for entry inhibitors and vaccine-induced neutralizing antibodies. Env interstrain variability, conformational flexibility and heavy glycosylation contribute to evasion of the host immune response, and create challenges for structural characterization and vaccine development. Here we investigate variables associated with reconstitution of the HIV-1 Env precursor into nanodiscs, nanoscale lipid bilayer discs enclosed by membrane scaffolding proteins. We identified detergents, as well as lipids similar in...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, which consists o...
The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a ...
ABSTRACT: Immunization strategies that elicit antibodies capable of neutralizing diverse virus strai...
© 2017 Dr Christopher Andrew GonelliA prophylactic vaccine eliciting broadly neutralising antibody (...
A major step toward an HIV-1 vaccine is an immunogen capable of inducing neutralizing antibodies. En...
HIV-1 is a major threat to global health and a vaccine is not yet on the horizon. A successful HIV-1...
SummaryA major step toward an HIV-1 vaccine is an immunogen capable of inducing neutralizing antibod...
The HIV-1 envelope glycoprotein spike is the target of neutralizing antibody attack, and hence repre...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, which consists o...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, which consists o...
The enormous sequence diversity between human immunodeficiency virus type 1 (HIV-1) strains poses a ...
ABSTRACT: Immunization strategies that elicit antibodies capable of neutralizing diverse virus strai...
© 2017 Dr Christopher Andrew GonelliA prophylactic vaccine eliciting broadly neutralising antibody (...
A major step toward an HIV-1 vaccine is an immunogen capable of inducing neutralizing antibodies. En...
HIV-1 is a major threat to global health and a vaccine is not yet on the horizon. A successful HIV-1...
SummaryA major step toward an HIV-1 vaccine is an immunogen capable of inducing neutralizing antibod...
The HIV-1 envelope glycoprotein spike is the target of neutralizing antibody attack, and hence repre...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, which consists o...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
Generation of a stable, soluble mimic of the HIV-1 envelope glycoprotein (Env) trimer on the virion ...
A highly glycosylated, trimeric envelope glycoprotein (Env) mediates HIV-1 cell entry. The high dens...
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer, which consists o...